BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 12204494)

  • 1. Optimizing the diabetic formulary: beyond aspirin and insulin.
    Marso SP
    J Am Coll Cardiol; 2002 Aug; 40(4):652-61. PubMed ID: 12204494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving the pharmacological regimen for patients with diabetes mellitus.
    Marso SP
    Rev Cardiovasc Med; 2004; 5(3):139-47. PubMed ID: 15346097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular risk management in type 2 diabetes of more than 10-year duration: Results of Polish ARETAEUS2-Grupa Study.
    Leśniak W; Bała MM; Płaczkiewicz-Jankowska E; Topór-Mądry R; Jankowski M; Sieradzki J; Banasiak W;
    Cardiol J; 2015; 22(2):150-9. PubMed ID: 25299503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cardiovascular event in elderly patients with diabetes mellitus].
    Nomura K
    Nihon Rinsho; 2013 Nov; 71(11):1954-9. PubMed ID: 24397165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes mellitus: a cardiovascular disease.
    Candido R; Srivastava P; Cooper ME; Burrell LM
    Curr Opin Investig Drugs; 2003 Sep; 4(9):1088-94. PubMed ID: 14582453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regarding "Pharmacologic risk factor management in peripheral arterial disease: a vade mecum for vascular surgeons".
    Paraskevas KI
    J Vasc Surg; 2008 Sep; 48(3):776-7; author reply 777. PubMed ID: 18727983
    [No Abstract]   [Full Text] [Related]  

  • 7. Metformin: effects on cardiovascular risk factors in patients with non-insulin-dependent diabetes mellitus.
    Palumbo PJ
    J Diabetes Complications; 1998; 12(2):110-9. PubMed ID: 9559489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of co-existing diabetes mellitus and dyslipidemia: defining the role of thiazolidinediones.
    Florkowski CM
    Am J Cardiovasc Drugs; 2002; 2(1):15-21. PubMed ID: 14727995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid lowering targets are easier to attain than those for treatment of hypertension in type 2 diabetes.
    Sherlock M; Mylotte D; Mac Mahon J; Moore KB; Thompson CJ
    Ir J Med Sci; 2006; 175(4):36-41. PubMed ID: 17312827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type II diabetes mellitus.
    Edelman SV
    Adv Intern Med; 1998; 43():449-500. PubMed ID: 9506190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of type 2 diabetes mellitus and cardiovascular risk: lessons from intervention trials.
    Yki-Järvinen H
    Drugs; 2000 Nov; 60(5):975-83. PubMed ID: 11129129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treating the diabetic patient: appropriate care for glycemic control and cardiovascular disease risk factors.
    Zarich SW
    Rev Cardiovasc Med; 2003; 4 Suppl 6():S19-28. PubMed ID: 14668700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New drugs and clinical trials in diabetes and hypertension.
    Nilsson P
    Exp Clin Endocrinol Diabetes; 1997; 105 Suppl 2():64-9. PubMed ID: 9288549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Potential of combined hypoglycemic, antihypertensive, and hypolipidemic therapy in patients with diabetes mellitus and diabetic foot syndrome].
    Onuchin SG; Elsukova OS; Onuchina EL
    Klin Med (Mosk); 2008; 86(8):61-6. PubMed ID: 18819351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes.
    Gaede P; Vedel P; Larsen N; Jensen GV; Parving HH; Pedersen O
    N Engl J Med; 2003 Jan; 348(5):383-93. PubMed ID: 12556541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Acute coronary syndrome in patients with carbohydrate metabolic disturbances (a review)].
    Kremneva LV; Shalaev SV
    Ter Arkh; 2009; 81(10):27-34. PubMed ID: 19947437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of cardiovascular events in diabetes.
    Malcolm J; Meggison H; Sigal R
    Clin Evid; 2003 Dec; (10):690-714. PubMed ID: 15555116
    [No Abstract]   [Full Text] [Related]  

  • 18. Cardiovascular disease and modifiable cardiometabolic risk factors.
    Cannon CP
    Clin Cornerstone; 2008; 9(2):24-38; discussion 39-41. PubMed ID: 19410160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reducing CV risk in diabetes: An ADA update.
    Skolnik N; Jaffa FM; Kalyani RR; Johnson E; Shubrook JH
    J Fam Pract; 2017 May; 66(5):300-308. PubMed ID: 28459890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular diseases and diabetes mellitus.
    Bandyopadhyay P
    Drug News Perspect; 2006; 19(6):369-75. PubMed ID: 16971974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.